COP
47
2
CPB
40
3
GE
72
4
LLY
53
6
UA
57
-8
DOV
69
2
RF
67
-2
KLAC
53
-3
SO
62
3
MO
65
5
INTC
40
-4
WMT
79
3
COST
66
3
VMC
60
-2
WBA
51
-3
CMCSA
48
-2
HCA
48
2
HBI
59
4
NEE
59
5
CVS
52
-6
COP
47
2
CPB
40
3
GE
72
4
LLY
53
6
UA
57
-8
DOV
69
2
RF
67
-2
KLAC
53
-3
SO
62
3
MO
65
5
INTC
40
-4
WMT
79
3
COST
66
3
VMC
60
-2
WBA
51
-3
CMCSA
48
-2
HCA
48
2
HBI
59
4
NEE
59
5
CVS
52
-6
Financhill
Back

ProShares Ultra Gold Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
50

UGL
ProShares Ultra Gold

Last Price:
94.90
Seasonality Move:
4.37%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
138.01
Seasonality Move:
14.88%
Sell
50
ProShares Ultra Gold (UGL) is a Sell

Is ProShares Ultra Gold a Buy, Sell or Hold?

  • The current ProShares Ultra Gold [UGL] share price is $94.45. The Score for UGL is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • UGL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

UGL Stock Price Chart

What is ProShares Ultra Gold's stock price today?

  • The ProShares Ultra Gold share price today is $94.45
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UGL is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

UGL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.01 Sell
Relative Strength Index (14 RSI): 45.43 Sell
Chaikin Money Flow: 138340 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (93.4 - 103.56) Sell
Bollinger Bands (100): (84.08 - 99.04) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

UGL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 94.97 Sell
20-day SMA: 97.21 Sell
50-day SMA: 97.94 Sell
200-day SMA: 83.11 Buy
8-day EMA: 95.42 Sell
20-day EMA: 96.46 Sell
50-day EMA: 95.98 Sell
200-day EMA: 84.71 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

ProShares Ultra Gold Earnings Growth & UGL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

ProShares Ultra Gold Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):